医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2012年
30期
334-335
,共2页
茅为涛%潘涛%刘芙成%欧艳
茅為濤%潘濤%劉芙成%歐豔
모위도%반도%류부성%구염
结肠镜%肠道清洁%福松+硫酸镁%辉灵
結腸鏡%腸道清潔%福鬆+硫痠鎂%輝靈
결장경%장도청길%복송+류산미%휘령
colonoscopy%bowel cleansing%forlax + magnesium%sulfate-Hui-ling
目的观察两种肠道清洁方法对结肠镜检查肠道准备的效果.方法将600例需行肠镜检查患者随机分成 a、b 两组,a 组为福松(聚乙二醇4000散)40g 加30g 硫酸镁粉剂组,b 组为辉灵(磷酸钠盐口服液)组.根据两组病例在结肠镜检查中肠道的清洁程度进行效果评价.结果福松+硫酸镁组肠道清洁率98%,肠道清洁范围Ⅲ度7.3%,Ⅳ度89.7%,不良反应7%;辉灵肠道清洁有效率95.6%,肠道清洁范围Ⅲ度12%,Ⅳ度83.7%不良反应17%.结论福松+硫酸镁组肠道清洁效果及清洁范围与辉灵组无显著差异(p >0.05),不良反应有显著差异(p<0.05).福松+硫酸镁组价格便宜,不良反应少,病员依从性好,可在临床推广应用.
目的觀察兩種腸道清潔方法對結腸鏡檢查腸道準備的效果.方法將600例需行腸鏡檢查患者隨機分成 a、b 兩組,a 組為福鬆(聚乙二醇4000散)40g 加30g 硫痠鎂粉劑組,b 組為輝靈(燐痠鈉鹽口服液)組.根據兩組病例在結腸鏡檢查中腸道的清潔程度進行效果評價.結果福鬆+硫痠鎂組腸道清潔率98%,腸道清潔範圍Ⅲ度7.3%,Ⅳ度89.7%,不良反應7%;輝靈腸道清潔有效率95.6%,腸道清潔範圍Ⅲ度12%,Ⅳ度83.7%不良反應17%.結論福鬆+硫痠鎂組腸道清潔效果及清潔範圍與輝靈組無顯著差異(p >0.05),不良反應有顯著差異(p<0.05).福鬆+硫痠鎂組價格便宜,不良反應少,病員依從性好,可在臨床推廣應用.
목적관찰량충장도청길방법대결장경검사장도준비적효과.방법장600례수행장경검사환자수궤분성 a、b 량조,a 조위복송(취을이순4000산)40g 가30g 류산미분제조,b 조위휘령(린산납염구복액)조.근거량조병례재결장경검사중장도적청길정도진행효과평개.결과복송+류산미조장도청길솔98%,장도청길범위Ⅲ도7.3%,Ⅳ도89.7%,불량반응7%;휘령장도청길유효솔95.6%,장도청길범위Ⅲ도12%,Ⅳ도83.7%불량반응17%.결론복송+류산미조장도청길효과급청길범위여휘령조무현저차이(p >0.05),불량반응유현저차이(p<0.05).복송+류산미조개격편의,불량반응소,병원의종성호,가재림상추엄응용.
objective: observation of two kinds of intestinal cleaning method effectiveness of colonoscopy bowel preparation. To: 600 patients with colonoscopy required rows randomly divided them into two groups a, b, a group of forlax (4,000 powder with polyethylene glycol) 40g increase 30g magnesium sulphate powder group, b group for Hui Ling (sodium phosphate oral solution) group. According to the two groups of cases in the colonoscopy examination of intestinal cleanliness evaluation. Results: forlax + magnesium sulfate group rates of intestinal cleaning 98%, intestinal cleaning range third-degree 7.3%, IV-89.7%, 7% adverse reactions; Hui-ling intestinal cleaning efficient 95.6%, – 12% intestinal cleaning area, IV 17%-83.7% adverse reactions. Conclusion: intestinal cleaning efficiency and cleaning area forlax + magnesium sulfate group and Hui-Ling group was not significantly different (p>0.05), significant differences in adverse reactions (p<0.05). Forlax + magnesium sulfate group is cheap, less adverse reactions, patient compliance, and clinical application.